Similarly, primary tumor cells originating from the CD133+/EpCAM+ spheroid CSC-derived xenograft tumors exhibited a higher proliferative potential under the stem cell conditions compared to those from CD133−/EpCAM+ cell-derived xenograft tumors (Fig. 4C). The gene discussed is EPCAM; the disease is neoplasm.